Integrum is a world-leading company within bone-anchored prostheses and has since the start, in 1990, been helping individuals with amputations towards an improved life quality. As a result of a strong commercial development and expansion, the company has decided to relocate the headquarter to new premises in GoCo House and will thus join the innovative cluster now taking shape in Mölndal.
Integrum is a publicly traded company with a US subsidiary in San Francisco. Performing continuous research and development, Integrum aims at providing safe medical devices, supporting a more active lifestyle. The company’s implant system, OPRA™, is an innovative method allowing direct connection of an artificial limb to the skeleton with the result giving amputees the ability to once again enjoy what most people take for granted. Free movement and feeling the ground you are walking on.
- We are thrilled to have companies that are at the forefront of the respective industry moving into GoCo House. It is together that we can create innovation and change the opportunities for tomorrow. With Integrum's expertise and mission, the company will bring a lot of value in itself. Integrum will also be an inspiring business both in terms of collaborations and future world-class innovation, Jonas Obert, business developer at GoCo Health Innovation City.
GoCo House is designed by architects Semrén & Månsson and will when it's ready become the center of the new life science district. Companies such as Ribocure Pharmaceuticals and Siemens Healthineers have already signed up as tenants and is now joined by Integrum.
- We look forward to joining the innovative and collaborative environment in GoCo Health Innovation City. Besides providing us with the space we need for our ongoing expansion, we believe the relocation will make us an even more attractive employer to the best minds in the field,” comments Rickard Brånemark, CEO of Integrum.
We use cookies to ensure that we give you the best experience on our website. By continuing to browse the site you are agreeing to our use of cookies. Read more about our data and privacy policy here.
OK